This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • SPYRAL HTN-ON MED Study
Clinical trial

SPYRAL HTN-ON MED Study

Read time: 2 mins
Last updated:1st Jul 2015
Identifier: NCT02439775

The purpose of this study is to obtain an assessment of the efficacy and safety of renal denervation in the presence of three standard antihypertensive medications.


Study Type: Interventional  (Clinical Trial)
Actual Enrollment: 106 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Actual Study Start Date: July 2015
Estimated Primary Completion Date: January 2021
Estimated Study Completion Date: February 2021

Arm:
- Experimental:
Renal Denervation
- Sham Comparator: Sham Procedure


Related journal:
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.

Category Value
Date last updated at source 2018-04-17
Study type(s) Interventional
Expected enrolment 106
Study start date 2015-07-01
Estimated primary completion date 2021-01-01

View full details